Release Date: 16/02/15 16:08 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 274.06KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%